SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001161697-24-000185
Filing Date
2024-04-03
Accepted
2024-04-03 16:31:12
Documents
4
Period of Report
2024-04-03

Document Format Files

Seq Description Document Type Size
1 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER FOR APRIL, 2024 form_6-k.htm 6-K 9819
2 INVITATION TO THE EXTRAORDINARY GENERAL SHAREHOLDERS' MEETING OF RELIEF THERAPEU ex_99-1.htm EX-99 59068
3 PRESS RELEASE DATED MARCH 27, 2024 ex_99-2.htm EX-99 15392
4 GRAPHIC rt_logo.jpg GRAPHIC 11881
  Complete submission text file 0001161697-24-000185.txt   101921
Mailing Address AVENUE DE SECHERON 15 CH-1202 GENEVA V8 NA
Business Address AVENUE DE SECHERON 15 CH-1202 GENEVA V8 NA 914-672-3555
Relief Therapeutics Holding SA (Filer) CIK: 0001854078 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41174 | Film No.: 24819265
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)